Picture EBD Group BioPharm America 2018 Boston Partnering 600x60px
Organisation › Details

Kiadis (Group)

Kiadis Pharma B.V. is a private, clinical stage biopharmaceutical company focused on the development of innovative and potentially life-saving therapies for patients with late stage blood cancers and related disorders, an area of significant unmet medical need. Kiadis Pharma's lead product is ATIR™, a T-cell immunotherapy based medicinal product designed to enable stem cell transplantations from partially mismatched (haploidentical) family donors. Kiadis Pharma is collaborating with internationally renowned centers in Europe and North America for the successful development and manufacturing of ATIR™. Kiadis Pharma is working under a GMP manufacturing license and GMP certificate for its Quality Control laboratory. Kiadis Pharma is supported by a strong group of leading international investors including LSP, DFJ Esprit, Alta Partners, Quest for Growth, NOM and MedSciences Capital. Kiadis Pharma is based in Amsterdam, The Netherlands. *


Period Start 2002-05-01 renamed
  Predecessor Screentec B.V.
Products Industry cancer drug
  Industry 2 ATIR™ (Kiadis)
Persons Person Lahr, Arthur (Kiadis 201704– CEO before Crucell 200701 Chief Strategy Officer + EP Sales + BusDev)
  Person 2 van Heekeren, Robbert (Kiadis Pharma 201604 CFO)
Region Region Amsterdam
  Country Netherlands
  Street 231–234 Entrada
  City 1114 AA Amsterdam
  Tel +31-20-3140250
    Address record changed: 2016-08-28
Basic data Employees n. a.
  Currency EUR
  Profit -14,758,000 (2016-12-31)
  Cash 14,559,000 (2016-12-31)
    * Document for �About Section�: Kiadis Pharma B.V.. (9/3/14). "Press Release: Kiadis Pharma Appoints Jeroen Rovers as Its Chief Medical Officer. Clinical and Business Development Expert Re-joins the Company". Amsterdam.
Record changed: 2017-08-23


Picture [LSUK] – The Business Web Portal 600x80px

More documents for Kiadis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Fairtec GmbH Worldwide Event Solutions 600x60px

» top